The health system reported favorable second quarter results, but investor worries around reduced volumes and policy impacts remain.

The company raised its FY2025 adjusted EPS guidance from $11.99-$13.12 to $15.55-$16.21 and also increased its sales guidance ...

Tenet’s ambulatory business, United Surgical Partners International, “continues to deliver” for the Dallas-based system, Chairman and CEO Saum Sutaria, MD, said on the Dallas-based system’s July 22 ...

Tenet Healthcare has consistently beaten earnings every quarter for years, and higher guidance suggests they will for the ...

Discover key insights from Tenet Healthcare's Q2 2025 earnings call—strong financial performance, raised guidance, USPI growth, and increased ...